Skip navigation

Join us at ERBI's 11th Annual Cambridge BioPartnering Exchange - Europe's Largest Biocluster Gathering

 
 

Wellcome Trust Genome Campus, Cambridge, UK

10-12 June 2009

2009 Conference Sponsors

Related Links

2007 Programme
2006 Programme

2008 Conference

Photos from CBE 2008

Videos from CBE 2008

Contact

conference@erbi.co.uk
Tel: 01223 497401

Day 3

Friday 12 June 2009

Disruptive Technologies in Life Sciences - Technology Showcase

Disruptive technologies are innovations which have the potential to fundamentally affect the status quo, changing the industry paradigm and superseding the established technology in a given sector. This year we will focus on three key disruptive technologies: stem cell technology, systems biology and personalised medicine.
Each session will be introduced by an industry speaker who will give a perspective on the latest technology developments in the sector, followed by a showcase of cutting-edge academic research. Partnering sessions will also take place throughout the day.

09:00

Registration

09:30

Introduction to London Technology Network

Jolyon White, Technology Consultant, LTN
 

Stem Cell Technology
09:55

Industry Perspective

The translation of stem cell science into a therapy (cell therapy, regenerative medicine, stem cell simulation and migration in vivo) and its role in drug discovery and drug development will be examined in this session. The session will also address the role of academics and the
value of public sector funded research to industry.

Chairing the session:
Dr Miriam Bibel, Senior Research Investigator, Neuroscience/Neurodegeneration, Novartis
10:10

Academic Technology Showcase

Spotlight on the latest research on stem cell sciences from London Technology Network’s Business Fellows.

Speakers include:

  • Professor Robin Franklin,
    University of Cambridge
  • Dr Mark Lewis, Eastman Dental Institute, UCL
  • Professor Liam Gray, University of Southampton
  • Dr Harry Witchel, University of Sussex
10:40

Panel Discussion

11:10

Networking break with academic posters
 

Systems Biology
11:40

Industry Perspective

One of the core aims of systems biology is to approach and explore biological processes from a systemic view; observing effects in multiple closely-related systems. This session will address new developments centred on our ability to record, integrate and comprehend data from a wide range of experimental sources using multiple techniques including: mathematical modelling; metabolomics; proteomics; and transcriptomics.

Chairing the session:
Dr Gerhard Engel, Senior Manager, Accelrys Ltd
11:55

Academic Technology Showcase

Spotlight on the latest research on systems biology from London Technology Network’s Business Fellows.

Speakers include:

  • Dr Jules Griffin, University of Cambridge
  • Dr Andrzej M Kierzek, University of Surrey
  • Dr Clare Sansom, University of London
  • Dr Kieran Tuohy, University of Reading
12:25

Panel Discussion
12:55

Networking lunch with academic posters
 

Personalised Medicine
14:00

Industry Perspective

The growth of personalised medicine has led to the increased interest in the identification, development and validation of biomarkers. In this session we will explore the current technologies spanning the life and physical science fields that are responsible for allowing
the detection and development of biomarkers to become a commercial reality. We will also address the use of biomarkers in inflammatory disorders and look at the future implications of personalised medicine for the healthcare industry and its potential benefits for patient care.

Chairing the session:
Dr Chris Chamberlain, BioMarker Expert, Roche
14:15

Academic Technology Showcase

Spotlight on the latest research on personalised medicine from London Technology Network’s Business Fellows.

Speakers include:

  • Professor Tony Turner, Cranfield University
  • Dr Chris Parris, Brunel University
  • Dr Rajshree Mootanah,
    Anglia Ruskin University
  • Dr Sotiris Missailidis, The Open University
14:45

Panel Discussion
15:15

End of Technology Showcase

Cluster Presentation Session

 

Biotechnology as an industry in Europe is relatively young, with its roots in the early biotechnology companies which emerged in the 1980’s through entrepreneurs such as Sir Christopher Evans whose first company was set up in the Cambridge region. In this session we hear company presentations from three global leading regions.

 

09:00

Registration

09:30

Welcome and Introduction - Jeanette Walker, Business Development Director, ERBI

  Overview of the Chinese Bio-pharmaceutical Industry Ting Zhang, CEO, China Business Solutions Ltd
 

Introduction to BioBay

Rong Hui , Manager, BioBay
 

Chinese Buisness Culture

Chris Cotton, Director

China - Britain Business Council

  Navigating the Intellectual Property Landscape in China

Michael Roberts, Associate

Reddie & Grose

  Case Study - Outsourcing Chemistry to China

David Walker, Program Manager

Sentinel Oncology

  Panel Discussion
10:30

Coffee Break

11:00

Overview of Canada's Life Sciences

Laetitia MacDougall, Health Industries & Investment Officer

Canadian High Commission

  Allphase Clinical Research Inc Philip Sinclair, Director of Scientific and Clinical Affairs
  Axela Paul Smith, VP Sales and Business Planning
  CMX Research Inc Zsuzsanna Gesztesi, MD, President
  Diteba Research Laboratories Marc Routhier, Director, Business Development
  Spartan Bioscience Inc Jay Rau, Director, Business Development
  Therapure Biopharma Inc Rajan Puri, Director of Business Development
12:00

Introduction to the European Business and Technology Centre in India including business support available to European companies

Jeanette Walker, Business Development Director, ERBI

  Smart Sourcing - India Chandra Rao, Executive Director, Laxai Avanti Life Sciences Pvt. Ltd
  LAXAI - Affordable Innovation

Patricia Lobo , Business Development Director,

Laxai Avanti Life Sciences Pvt. Ltd

  Doing Clinical Trials in India

Jamila Joseph, General Manager

Reliance Clinical Research Services

 

Case Study

Sourcing Medicinal Chemistry India

Dr Mark Treherne, CEO

Senexis

13:00

Close and Networking Lunch

© 2008 ERBI